Literature DB >> 14983950

ERSPC: features and preliminary results of France.

A Villers1, B Malavaud, X Rebillard, V Bataille, F Iborra.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 14983950     DOI： 10.1111/j.1464-410x.2003.04392.x

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  3 in total

Review 1.  Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based Analysis.

Authors:  G Pron
Journal:  Ont Health Technol Assess Ser       Date:  2015-05-01

2.  A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France.

Authors:  Amine Benchikh; Caroline Savage; Angel Cronin; Gilles Salama; Arnauld Villers; Hans Lilja; Andrew Vickers
Journal:  BMC Cancer       Date:  2010-11-22       Impact factor: 4.430

3.  Epidemiological study of prostate cancer (EPICAP): a population-based case-control study in France.

Authors:  Florence Menegaux; Antoinette Anger; Hasina Randrianasolo; Claire Mulot; Pierre Laurent-Puig; François Iborra; Jean-Pierre Bringer; Benoit Leizour; Rodolphe Thuret; Pierre-Jean Lamy; Xavier Rébillard; Brigitte Trétarre
Journal:  BMC Cancer       Date:  2014-02-19       Impact factor: 4.430
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.